Story

Vossloh Shares Plunge to 52-Week Low After Slashing Full-Year Guidance

ENTHMSVIIDZHZH-TWJAKOHI
Jul 14, 20262 min read
Vossloh Shares Plunge to 52-Week Low After Slashing Full-Year Guidance

Summary

German rail technology firm Vossloh saw its shares tumble nearly 10% after issuing a significant profit warning, cutting its 2026 revenue and earnings forecasts due to project delays and rising costs.

Text size
Background

Shares of Vossloh AG (VOSG) plunged on Tuesday, hitting a new 52-week low, after the rail infrastructure company significantly lowered its financial outlook for the full year 2026, citing a challenging economic environment and operational headwinds.

The stock fell by as much as 9.8% to trade at €56.20 following the announcement, a sharp decline from its 52-week high of €95.10.

Revised 2026 Forecast

Vossloh issued a profit warning, cutting its guidance for key financial metrics. The company attributed the revision to macroeconomic and geopolitical uncertainties, delayed project deliveries into 2027, and lower-than-expected call-offs from existing framework contracts.

  • Revenue: The forecast was lowered to a range of €1,510–€1,610 million, down from the previous €1,560–€1,660 million.
  • EBITDA: The outlook was cut to €195–€210 million, compared to the prior range of €215–€230 million. This new target fell short of analyst expectations.
  • EBIT: Guidance was reduced to €100–€110 million from the previous €118.5–€131 million.

The company also noted that higher procurement and logistics costs could not be fully passed on to customers, further pressuring profitability.

Sample IUX Markets – In-articleAd

Margin Erosion in First-Half Results

Preliminary results for the first half of 2026 underscored the company's profitability challenges. While revenues grew to €710.1 million from €582.6 million in the same period last year, earnings before interest and taxes (EBIT) declined sharply.

First-half EBIT fell to €32.4 million, a significant drop from the €44.9 million reported in the first half of the prior year. This divergence between revenue growth and declining EBIT points to meaningful margin erosion, a key concern for investors.

Market Context

The sell-off occurred amid a weaker session for German equities, with the DAX index declining 0.47%. Broader market sentiment was impacted by geopolitical news, including a U.S. announcement of a renewed naval blockade on Iranian shipping, which pushed crude oil prices to a one-month high and stoked fears of rising costs across global supply chains.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST